THQ logo

Tekla Healthcare Opportunities Fund (THQ) Financials

Balance sheets

30 Sept 202431 Mar 202430 Sept 202331 Mar 202330 Sept 202231 Mar 202230 Sept 202131 Mar 2020

Total Assets

$1.2 B(+1.8%)$1.2 B(+8.5%)$1.1 B(-3.5%)$1.1 B(+3.3%)$1.1 B(-12.5%)$1.2 B(-1.7%)$1.2 B-

Current Assets

-----$6.1 M(+163.9%)$2.3 M-

Non Current Assets

-----$1.2 B(-2.0%)$1.2 B-

Total Liabilities

$229.2 M(-0.4%)$230.1 M(+0.2%)$229.5 M(-0.8%)$231.4 M(+0.4%)$230.4 M(-0.7%)$232.0 M(-11.8%)$263.0 M-

Current Liabilities

-----$665.8 K(-98.1%)$35.4 M-

Long Term Liabilities

-----$665.8 K(-99.7%)$225.0 M-

Shareholders Equity

$943.9 M(+2.3%)$922.4 M(+10.8%)$832.5 M(-4.2%)$869.2 M(+4.0%)$835.6 M(-15.3%)$986.9 M(+1.0%)$977.4 M-

Book Value

$943.9 M(+2.3%)$922.4 M(+10.8%)$832.5 M(-4.2%)$869.2 M(+4.0%)$835.6 M(-15.3%)$986.9 M(+1.0%)$977.4 M-

Working Capital

-----$5.5 M(+116.5%)-$33.1 M-

Cash And Cash Equivalents

-$61.2 K(+11279.9%)$538.0(+3486.7%)$15.0(-98.4%)$919.0(+13.5%)$810.0(-13.1%)$932.0-

Accounts Payable

-$2.7 M(-4.0%)$2.8 M(+15.5%)$2.4 M(+62.1%)$1.5 M(+125.5%)$665.8 K(-98.1%)$35.4 M-

Accounts Receivable

-----$6.1 M(+164.0%)$2.3 M-

Short Term Debt

-----$0.0(0%)$0.0-

Long Term Debt

$225.0 M(0%)$225.0 M(0%)$225.0 M(0%)$225.0 M(0%)$225.0 M(0%)$225.0 M(0%)$225.0 M-

Total Debt

$225.0 M(0%)$225.0 M(0%)$225.0 M(0%)$225.0 M(0%)$225.0 M(0%)$225.0 M(0%)$225.0 M-

Debt To Equity

0.2(0%)0.2(-11.1%)0.3(+3.9%)0.3(-3.7%)0.3(+17.4%)0.2(0%)0.2-

Current Ratio

-----9.2(+13042.9%)0.1-

Quick Ratio

-----9.2(+13042.9%)0.1-

Inventory

-----$0.0(0%)$0.0-

Retained Earnings

$184.5 M(+41.8%)$130.1 M(+223.9%)$40.2 M(-47.7%)$76.8 M(+77.8%)$43.2 M(-77.8%)$194.5 M(+5.0%)$185.3 M-

PB Ratio

--------

Income statements

30 Sept 202431 Mar 202430 Sept 202331 Mar 202330 Sept 202231 Mar 202230 Sept 202131 Mar 2020

EPS

--------$0.6

TTM EPS

--------$0.7

Revenue

-------$11.5 M

TTM Revenue

-------$22.7 M

Total Expenses

-------$9.1 M

Operating Expenses

-------$246.3 K

Cost Of Goods Sold

-------$8.9 M

TTM Cost Of Goods Sold

-------$18.3 M

Gross Profit

-------$2.6 M

TTM Gross Profit

-------$4.4 M

Gross Margin

-------22.4%

Operating Profit

-------$2.3 M

TTM Operating Profit

-------$3.9 M

Operating Margin

-------20.3%

Net Income

--------$25.3 M

TTM Net Income

--------$28.8 M

Net Margin

--------220.5%

EBIT

--------$52.9 M

TTM EBIT

--------$61.5 M

EBITDA

--------$52.9 M

TTM EBITDA

--------$61.5 M

Selling, General & Administrative Expenses

-------$246.3 K

TTM SG&A

-------$480.3 K

Depreciation And Amortization

--------$55.2 M

TTM D&A

--------$65.5 M

Interest Expense

--------$27.6 M

TTM Interest Expense

--------$32.7 M

Income Tax

-------$0.0

TTM Income Tax

-------$0.0

PE Ratio

--------

PS Ratio

--------

Cashflow statements

30 Sept 202431 Mar 202430 Sept 202331 Mar 202330 Sept 202231 Mar 202230 Sept 202131 Mar 2020

Cash From Operations

-------$23.5 M

TTM CFO

-------$39.6 M

Cash From Investing

-------$0.0

TTM CFI

-------$0.0

Cash From Financing

--------$30.0 M

TTM CFF

--------$54.6 M

Free Cash Flow

-------$23.5 M

TTM FCF

-------$39.6 M

CAPEX

-------$0.0

TTM CAPEX

-------$0.0

Dividends Paid

-------$28.0 M

TTM Dividends Paid

-------$56.0 M

TTM Dividend Per Share

$1.89(+27.3%)$1.49(+10.0%)$1.35(0%)$1.35(0%)$1.35(0%)$1.35(0%)$1.35(0%)$1.35

TTM Dividend Yield

8.4%(+13.5%)7.4%(-7.0%)8.0%(+10.4%)7.2%(-3.4%)7.5%(+22.9%)6.1%(+1.7%)6.0%(-32.2%)8.8%

Payout Ratio

--------110.7%